About Us
Zhida Therapeutics is a privately held, university spin-off company dedicated to cutting-edge biomedical research with a vision of providing lifelong cures to patients sufferring serious diseases.
We focus on developing novel biopharmaceutical products for unmet medical needs, with a focus on Duchenne muscular dystrophy. The company is built around our innovation in engineering novel adeno-associated virus and breaking its limit to deliver large therapeutic genes. This innovation allows us to deliver full-length dystrophin gene to provide maximal protection to the weakened muscle and heart. Learn more about our science and technology. R&D efforts at Zhida Therapeutics focus on providing proof-of-concept support to validate our technology and facilitate partnerships with various established companies in the biomedical field.
